MagForce AG Announces Collaboration Agreement for NanoTherm® Therapy with Independent Public Clinical Hospital No. 4, Lublin, Poland
MagForce AG (Frankfurt, Scale, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today announced that it has entered into a collaboration agreement with Independent Public Clinical…